Virpax Pharmaceuticals In...
0.35
0.00 (0.29%)
At close: Jan 15, 2025, 3:59 PM
0.34
-2.06%
After-hours Jan 15, 2025, 07:54 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 9.14M 19.00M 36.84M 54.80K 41.54K 48.37K
Short-Term Investments n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a n/a n/a 392.34K n/a n/a
Receivables n/a n/a n/a n/a 1.39K n/a
Inventory n/a n/a n/a n/a 3.33K n/a
Other Current Assets 702.98K 678.37K 2.73M 18.27K 3.79K 13.13K
Total Current Assets 9.63M 19.67M 39.57M 73.07K 46.72K 61.50K
Property-Plant & Equipment n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets n/a n/a n/a 392.34K n/a n/a
Total Assets 9.63M 19.67M 39.57M 465.41K 46.72K 61.50K
Account Payables n/a 37.64K 19.84K 22.11K 3.50K 6.55K
Deferred Revenue n/a n/a n/a -1.05M -3.5 -6.55K
Short-Term Debt n/a n/a n/a 543.99K 1.26M 500.00K
Other Current Liabilities 7.69M 3.06M 2.06M 3.08M 1.50M 740.21K
Total Current Liabilities 7.69M 3.09M 2.09M 3.66M 2.78M 1.25M
Long-Term Debt n/a n/a n/a 1.02M n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities n/a 1.09K n/a 1.02M n/a 500.00K
Total Liabilities 7.69M 3.09M 2.09M 4.68M 2.78M 1.25M
Total Debt n/a n/a n/a 1.57M 1.26M 500.00K
Common Stock 12.00 117.00 117.00 31.00 30.00 29.00
Retained Earnings -59.54M -44.35M -22.70M -10.65M -6.31M -3.00M
Comprehensive Income -0.00 -0.00 -0.00 n/a -0.00 n/a
Shareholders Equity 1.93M 16.58M 37.48M -4.22M -2.73M -1.19M
Total Investments n/a n/a n/a n/a n/a n/a